McKesson Corporation (MCK)
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreKey Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
|
Mr. Brian S. Tyler Ph.D.
|
CEO & Chairman | 7.01M | -- | 1967 |
|
Ms. Michele Lau J.D.
|
Executive VP & Chief Legal Officer | 1.94M | -- | 1976 |
|
Ms. LeAnn B. Smith
|
Executive VP & Chief Human Resources Officer | 1.75M | -- | 1975 |
|
Mr. Kenny K. Cheung
|
Executive VP & CFO | -- | -- | 1982 |
|
Mr. Napoleon B. Rutledge Jr.
|
Senior VP, Controller & Chief Accounting Officer | -- | -- | 1973 |
|
Paula Adkison
|
Senior Vice President of Corporate Finance, Investor Relations & Strategic Finance | -- | -- | -- |
|
Mr. Francisco J. Fraga
|
Executive VP, Chief Information Officer & CTO | -- | -- | 1973 |
|
Ms. Jeni Dominguez
|
Head of Investor Relations | -- | -- | -- |
|
Mr. Kirk Kaminsky
|
Executive VP & Group President of North American Pharmaceutical Services | -- | -- | -- |
|
Mr. Stanton J. McComb
|
President of Medical-Surgical | -- | -- | -- |
McKesson Corporation
- Sector:
- Healthcare
- Industry: Medical Distribution
- Full Time Employees:
- 41,600
Description
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products; delivers products to retail pharmacies, hospitals, long-term care centers, clinics, and institutions; and provides logistics and distribution services for manufacturers. It also provides consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies; gene therapy with InspiroGene, practice consulting, and vaccine distribution services; and technology solutions, as well as research, insights, technologies, and services to improve cancer and specialty care. In addition, the company helps in solving medication access, affordability, and adherence challenges for patients by working across healthcare to connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies. Further, it offers technology services, which includes electronic prior authorization, prescription price transparency, benefit insight, dispensing support services, patient enrollment, third-party logistics, and wholesale distribution support; medical-surgical supplies, laboratory equipment, pharmaceutical distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, hospital reference labs, nursing homes, hospice and home health care agencies, government facilities, and online marketplaces and retailers. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
Corporate Governance
Upcoming Events
November 4, 2026 at 8:00 PM UTC
McKesson Corporation Earnings Date
December 1, 2026 at 12:00 AM UTC
Ex-Dividend Date
January 4, 2027 at 12:00 AM UTC
Dividend Date
Recent Events
May 28, 2026 at 12:00 AM UTC
SD: Specialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)
